With all the fanfare about Mars rover Curiosity landing safely on the Red Planet on Aug. 6, it’s easy to forget that there’s already a rover on Mars — an older, smaller cousin set to accomplish a feat unprecedented in the history of Solar System exploration. WUSTL’s Raymond E. Arvidson is playing key roles in both Mars missions.
A team of WUSTL scientists have vaporized the Earth — if only by simulation, that is, mathematically and inside a computer. They weren’t just practicing their evil overlord skills. By baking model Earths, they are trying to figure out what astronomers should see when they look at the atmospheres of super-Earths in a bid to learn the planets’ compositions.
The Department of Energy (DOE) announced that a
team of engineers at WUSTL will receive $2
million to design a battery management system for lithium-ion batteries
that will guarantee their longevity, safety and performance. These technologies could revolutionize the way Americans store and use energy in electric vehicles, the electrical grid and beyond.
Researchers at Washington University School of Medicine in St. Louis have identified a potential target for treating diabetes and obesity. Studying mice, they found that when the target protein was disabled, the animals became more sensitive to insulin and were less likely to get fat.
The federal government is in the process of revising the regulations that govern most human subject research in the United States. In a “Policy Forum” piece in the Aug. 3 issue of Science, bioethics expert Rebecca Dresser, JD, the Daniel Noyes Kirby Professor of Law and professor of ethics in medicine, weighs in with recommendations for changes in the oversight
process.
Giving antibiotics before cesarean section surgery rather than just after the newborn’s umbilical cord is clamped cuts the infection rate at the surgical site in half, according to infection disease specialist David K. Warren, MD, and his colleagues at Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital.
This summer, Ronald Levin, JD, the William R. Orthwein Distinguished Professor of Law, testified before the House of Representatives’ Subcommittee on Courts, Commercial and Administrative Law regarding the “retrospective review” process for federal agency rules.
Applications for the K12 Clinical Hematology Research Career Development Program scholars are being accepted through Oct. 22. The K12 Career Development Program is aimed at clinical or research fellows, instructors or recently appointed assistant professors committed to research in non-malignant hematology.
